Hassan E., Gumudavelli S.
Pharmaceutics International Inc. (Pii), US
Keywords: dissolution, manufacturing, nanoparticles, pharmaceutical process development
Process design and development of oral, topical and parentral nanotechnology-based pharmaceuticals are presented. Factors affecting process output and scale-up choices for various dosage forms are discussed with emphasis on critical parameter control and optimization. For example, effect of process variables on nanoparticles crystal form, shape, size, as well as nanoparticles stabilization, purification and yield are elaborated. Quality control testing and design of accelerated stability studies for nanoparticles-containing pharmaceuticals are detailed. Finally, integrating nanoparticles manufacturing equipment into conventional equipment trains used for large scale production of tablets, capsules as well as parentral and topical suspensions are demonstrated using selected model drugs.
Journal: TechConnect Briefs
Volume: 2, Nanotechnology 2009: Life Sciences, Medicine, Diagnostics, Bio Materials and Composites
Published: May 3, 2009
Pages: 83 - 84
Industry sector: Medical & Biotech
Topics: Biomaterials, Materials for Drug & Gene Delivery
ISBN: 978-1-4398-1783-4